A Phase 1 Study of XmAb18968, a CD3-CD38 Bispecific Antibody for the Treatment of Patients with Relapsed/Refractory Acute Leukemia and T Cell Lymphoblastic Lymphoma - Guru Murthy, Guru Subramanian; Kearl, Tyce J; Cui, Weiguo; Johnson, Bryon; Hoffmeister, Karin; Szabo, Aniko; Aoki, Kazuhiro; Harrington, Alexandra M.; Carlson, Karen; Michaelis, Laura C.; Runaas, Lyndsey; Abedin, Sameem; et al. (Blood, 2021)